Tanweera Shaheena Khan
Physician at Institutionen för medicinska vetenskaper; Endokrin tumörbiologi
- Telephone:
- +46 18 611 00 00
- E-mail:
- Tanweera.Khan@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Consultant at Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Peter Nygren
- Telephone:
- +46 18 611 00 00
- E-mail:
- tanweera.khan@igp.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 61, 3 tr
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ingång 61, 3 tr
751 85 Uppsala
- ORCID:
- 0000-0003-0679-9450
More information is available to staff who log in.
Publications
Recent publications
- 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy (2021)
- Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy (2020)
- Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs) (2018)
- Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving 177Lu-DOTATATE therapy (2018)
- One pot preparation of Ga-68-labelled macroaggregated albumin for PET-imaging of acute pulmonary embolism and myocardial perfusion quantification (2012)
All publications
Articles
- 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy (2021)
- Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy (2020)
- Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs) (2018)
- Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving 177Lu-DOTATATE therapy (2018)
- One pot preparation of Ga-68-labelled macroaggregated albumin for PET-imaging of acute pulmonary embolism and myocardial perfusion quantification (2012)
- Vincristine, Cisplatin, Teniposide and Cyclophosphamide Combination in the Treatment of Recurrent or Metastatic Adrenocortical Cancer (2004)
- 11C-metomidate PET imaging of adrenocortical cancer (2003)
- Labelling of octreotide using Br-76-prosthetic groups (2001)
- Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients (2000)
- PET with [11C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions (1999)
- Expression of c-Kit, phospho-c-kit, PDGFRβ and absence of c-Kit mutation in exon 11 in adrenocortical cancer